Del Pozo Ana Carolina, López Patricia
Recanati Miller Transplantation Institute, Mount Sinai Medical Center, One Gustave L Levy Place, Box 1106, New York, NY 10026, USA.
Clin Liver Dis. 2007 May;11(2):305-21. doi: 10.1016/j.cld.2007.04.007.
Hepatocellular carcinoma is the fifth most common cancer in the world and is the third cause of cancer-related death with varying prevalence according to endemic risk factors. Despite therapeutic advances, there has not been significant improvement in the overall survival of patients who have hepatocellular cancer in the last 2 decades. Treatment selection should be based on tumor characteristics and the underlying liver disease.
肝细胞癌是全球第五大常见癌症，是癌症相关死亡的第三大原因，其患病率因地区风险因素而异。尽管治疗取得了进展，但在过去20年里，肝细胞癌患者的总体生存率并未得到显著改善。治疗方案的选择应基于肿瘤特征和潜在的肝脏疾病。
